Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group

OBJECTIVE: To compare the safety and immunogenicity of two dosages of tetravalent rhesus rotavirus vaccine (RRV-TV) and the effect of age at dosing. METHODS: A total of 195 infants were stratified by age into 2 groups, 6 to 12 weeks and 16 to 24 weeks, and randomly assigned to receive a single dose of placebo or RRV-TV containing either 4 x 10(5) or 4 x 10(6) plaque-forming units (pfu). Symptoms were recorded for 5 days after vaccination. Anti-rotavirus IgA and neutralizing antibody to human rotavirus serotypes G1 to G4 and RRV were measured in serum obtained pre- and postvaccination. RESULTS: Rates of fever > 38 degrees C (9%), diarrhea (6%) and vomiting (8%) were similar in all groups. IgA (69% vs. 49%, P = 0.02) and RRV (85% vs. 66%, P = 0.004) seroconversion rates were significantly higher in the 4 x 10(6) pfu vaccine group as were antibody titers to RRV (440.2 vs. 263.7, P = 0.04). Older infants demonstrated significantly higher seroconversion rates and antibody titers for IgA (71% vs. 52%, P = 0.03; and 110.6 vs. 54.8, P = 0.004) and RRV (92% vs. 66%, P = 0.05 and 498.3 vs. 205.6, P = 0.01) at either dose level than did the younger infants. There were no significant differences in seroconversion rates or antibody titers to human rotavirus types G1 to G4 between the two vaccination groups. CONCLUSIONS: RRV-TV at a dose of 4 x 10(6) pfu can be safely administered to infants 6 to 24 weeks of age. A single dose of 4 x 10(6) pfu of RRV-TV was significantly more immunogenic than a single dose of 4 x 10(5) pfu but did not improve responses to the human serotypes. Older vaccine recipients demonstrated significantly higher IgA and neutralizing antibody seroconversion rates and antibody titers than younger infants independent of dosage.     

Effects of clinical ketosis on test day milk yields in Finnish Ayrshire cattle

A linear model for repeated measurements was used to estimate the effects of clinical ketosis on 722,198 test day milk yields collected from September 1, 1985 to January 31, 1988 on 60,851 Finnish Ayrshire cows of parity < 7. An index was created to differentiate among milk collected within 17 d following diagnosis of ketosis, milk collected before or > 17 d after diagnosis, and milk collected on nonketotic cows. For each parity separately, the statistical model included fixed effects (ketosis, calving season, year and season of milk sampling, and stage of lactation) and random effects (herd and permanent and temporary environments) on test day milk yields. The pattern underlying correlations between temporary environmental effects was accommodated in the statistical model. Compared with those for nonketotic cows, lactation curves of cows with ketosis showed a depression in early lactation; estimated milk loss was 44.3 kg for 17 d after diagnosis. The 305-d milk yield of cows diagnosed with ketosis was estimated to be 141.1 kg higher than that of cows free of ketosis. Although milk losses occurred after ketosis, ketotic cows yielded more milk over the entire lactation than did nonketotic cows; and yields would have been even higher if cows had not had ketosis.     

The evaluation of argon laser photocoagulation in a series of animal models of upper gastrointestinal bleeding

During the past five years we have evaluated argon laser photocoagulation in various canine models of upper gastrointestinal hemorrhage. In gastric erosions, the eight-watt argon laser was uniformly effective in stopping bleeding. In our standard acute ulcer model the seven-watt argon laser was effective in stopping bleeding from most ulcers and only occasionally produced deep injury. With the addition of a jet of CO2 exiting the laser catheter coaxial to the laser beam, the argon laser was 100% effective and no deep injury resulted. The application of the argon laser in a more physiologic canine bleeding model using a single bleeding vessel in an ulcer base is currently under study. The development of improved animal models of gastrointestinal bleeding should contribute to the identification of effective and safe endoscopic hemostatic methods.     

Framestore system for map displays

The map displays project was undertaken to investigate techniques for the storage and display of geographical maps and related information and to develop the hardware and software required for a complete working system. Initially most of the project was concerned with the design of graphics hardware to be interfaced to a DEC LSI-11/03 micro-computer which was the main supply of computing power for the project. The development of one of the pieces of specialized hardware, the framestore display, is described.